Anssure Pharma is a technology company.
Anssure Pharma has raised $9.0M across 1 funding round.
Anssure Pharma has raised $9.0M in total across 1 funding round.
Anssure Pharma is a pharmaceutical company specializing in the development, production, and marketing of external preparations, such as topical medications. It serves healthcare providers and patients by offering innovative external pharmaceutical products designed to address various therapeutic needs. The company focuses on delivering quality formulations that improve patient outcomes, particularly in dermatology and related fields. While specific growth metrics are not detailed in available sources, Anssure Pharma operates within a competitive pharmaceutical sector emphasizing product innovation and quality[2].
Detailed public information about Anssure Pharma’s founding year, founders, or early milestones is limited. However, the company is identified as a specialized pharmaceutical manufacturer focused on external preparations, suggesting a strategic niche within the broader pharmaceutical industry. This specialization likely emerged from recognizing a market need for high-quality topical and external-use medications in China, where the company is based[2].
Anssure Pharma rides the global trend of increasing demand for specialized pharmaceutical products, particularly in dermatology and external treatments. The timing aligns with rising awareness of skin health and chronic conditions requiring topical therapies. Market forces such as aging populations, increased healthcare access, and growing pharmaceutical innovation support the company’s focus. By concentrating on external preparations, Anssure Pharma contributes to diversifying pharmaceutical offerings and meeting specific patient needs within the healthcare ecosystem[2].
Looking ahead, Anssure Pharma is positioned to expand its product portfolio in external preparations, potentially leveraging advances in formulation technology and regulatory approvals to enhance market share. Trends such as personalized medicine, increased emphasis on dermatological health, and global pharmaceutical growth could shape its trajectory. Its influence may grow as it continues to innovate within its niche, contributing to improved patient care and specialized pharmaceutical solutions.
---
Note: There is some ambiguity in the query as "Anssure Pharma" closely resembles "Assure Pharma," an Indian pharmaceutical company with a broader product range and history. The information above pertains specifically to Anssure Pharma as identified in the search results, which is distinct and focused on external preparations in China[2]. If you intended information on Assure Pharma (India), please specify.
Anssure Pharma has raised $9.0M in total across 1 funding round.
Anssure Pharma's investors include Qiming Venture Partners.
Anssure Pharma has raised $9.0M across 1 funding round. Most recently, it raised $9.0M Series A in January 2017.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 1, 2017 | $9.0M Series A | Qiming Venture Partners |